Indraprastha Medical Corporation Limited — Important, 03-02-2025: Financial Result Updates

Indraprastha Medical Corporation Limited reported consolidated financial results for the quarter and nine months ended December 31, 2024.

Revenue from operations stood at ₹324.93 crore, reflecting a year-over-year growth of 6.82% from ₹306.46 crore in Q3 FY23, driven by increased patient inflow and market expansion efforts. Total income, which includes other income of ₹5.13 crore, reached ₹330.06 crore, up from ₹310.73 crore a year ago.

The net profit for the quarter was ₹32.81 crore, a 11.94% increase compared to ₹29.44 crore in the same period last year. Basic and diluted Earnings Per Share (EPS) were reported at ₹3.58, up from ₹3.21. This growth in profitability can be attributed to efficient cost management despite rising operational expenses.

Total expenses increased to ₹285.53 crore from ₹270.06 crore year-on-year, marking a 5.73% rise. Key drivers included higher employee benefits expenses and professional charges to doctors, contributing to the overall costs but reflecting investments in service quality.

With reserves of ₹386.09 crore, the balance sheet displays strong financial health. The company's strategic focus on operational efficiency and service enhancement positions it well for future growth.

Considering the financial performance and effective cost controls, the outlook leans positively, suggesting a hold position for investors, with attention to potential market and operational risks.